{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:49:21Z","timestamp":1788878961083,"version":"build-2803163510"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Point\u2010of\u2010care testing (POCT) for hematology enables clinicians to access actionable results during patient visits, supporting timely decisions such as transfusions or chemotherapy adjustments. However, POCT analyzers must demonstrate clinical performance comparable to centralized laboratory systems. We conducted a proof\u2010of\u2010concept evaluation of the HemoScreen (PixCell Medical, Israel) hematology POCT analyzer across diverse clinical settings in an integrated healthcare system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EDTA whole blood specimens from inpatient wards, emergency departments, outpatient clinics, and infusion centers underwent routine CBC testing on a Sysmex XN analyzer (Sysmex Corporation, Japan) at the central laboratory. Residual, de\u2010identified samples were tested within 10\u2009min on a HemoScreen analyzer. All parameters and instrument flags were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 9\/15\/2020 to 11\/20\/2020, 199 samples were analyzed, including 49 from the emergency department and 50 each from inpatient, outpatient, and infusion center settings. HGB, RBC, PLT, WBC, and absolute neutrophil count showed strong linear correlations (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.91\u20130.98) and no significant differences between instruments (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.29). HCT and MCV values were significantly lower on HemoScreen (bias \u22125% and \u22123.6%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010 and\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001, respectively), with modestly reduced correlations (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.80\u20130.89). Neutrophil percentage was higher on HemoScreen (bias +9.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), whereas monocyte counts were significantly lower (bias \u221250%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>HemoScreen demonstrated generally acceptable agreement with the Sysmex XN for most parameters. However, systematic differences in HCT, MCV, neutrophil, and monocyte results warrant further investigation to assess clinical impact before broader implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijlh.70032","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T08:42:06Z","timestamp":1765183326000},"page":"353-364","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Clinical Evaluation of a Novel Point\u2010of\u2010Care Hematology Analyzer for Complete Blood Count With Differential"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-4976","authenticated-orcid":false,"given":"Ryan C.","family":"Shean","sequence":"first","affiliation":[{"name":"ARUP Laboratories  Salt Lake City Utah USA"},{"name":"Department of Pathology University of Utah  Salt Lake City Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-6185","authenticated-orcid":false,"given":"Sterling T.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Utah  Salt Lake City Utah USA"},{"name":"Department of Pathology Intermountain Medical Center  Murray Utah USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043442"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqy165"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2024.04.001"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010019\u201054006\u20103"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2007.12.006"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfad050"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12561"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102141.2012.09207.x"},{"key":"e_1_2_11_10_1","unstructured":"R. L.Dark \u201cFDA Clears Waived CBC for Near\u2010Patient Testing The Dark Report \u201d(2017) https:\/\/www.darkintelligencegroup.com\/the\u2010dark\u2010report\/fda\u2010clears\u2010waived\u2010cbc\u2010near\u2010patient\u2010testing\u2010112017\/."},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2013.11669938"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1373\/jalm.2018.027383"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2010.054"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath\u20102015\u2010203484"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26295"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaa186"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875\u2010019\u20100971\u20102"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13330"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jha2.566"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751\u2010553X.2008.01050.x"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X8400400110"},{"key":"e_1_2_11_22_1","volume-title":"Differential Leukocyte Counting: CAP Conference, Aspen 1977","author":"Koepke J. A.","year":"1978"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"e_1_2_11_24_1","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2018.1557619"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.11.027"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12503"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.70032","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.70032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T16:33:41Z","timestamp":1772987621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.70032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/ijlh.70032"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.70032","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2025-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}